Mitochondrial diseases (mito) are a highly complex set of rare genetic disorders. Mito can cause any symptom in any organ at any age. They rob the body’s cells of energy causing debilitating and often life-threatening organ dysfunction.
About
MITO
NEWS
Funding for the SynLeigh Project to Advance New Therapies for Leigh Syndrome
Funding for the SynLeigh Project to Advance New Therapies for Leigh Syndrome IMP, Mitocon and Cure Mito Welcome ERDERA Funding International […]...
22 December 2025
Read more
IMP Annual Meeting 30-31 May 2026, France
IMP Annual Meeting 30-31 May 2026, France IMP’s Annual Meeting will take place 30–31 May 2026 at Brit Hotel Acropole, […]...
22 December 2025
Read more
Patients at the Heart of Research: IMP’s Role in the SIMPATHIC Drug Repurposing Project
Patients at the Heart of Research: IMP’s Role in the SIMPATHIC Drug Repurposing Project The SIMPATHIC project continues to make […]...
22 December 2025
Read more
Amplifying Our Collective Voice: IMP at National and International Events
Amplifying Our Collective Voice: IMP at National and International Events As members of IMP, we are part of a global […]...
22 December 2025
Read more
International MELAS Consensus Meeting in Pisa: A Milestone for Patient Advocacy and Research
International MELAS Consensus Meeting in Pisa: A Milestone for Patient Advocacy and Research From 28 to 30 November this autumn, […]...
22 December 2025
Read more
Meet
a member
The POLG Foundation
The PolG Foundation is committed to accelerating research efforts to develop effective treatments and, ultimately, a cure for POLG mitochondrial disorders.
Become
a member
Are you thinking of becoming an IMP member?
About
IMP
International Mito Patients is a non-profit network of national patient organisations involved in mito. The national patient organisations support and advocate for patients, fund research, increase awareness and improve education in their country.
By joining forces, IMP represents a large group of patients, creating a stronger voice on an international level.
IMP’s mission is to increase the quality of life for people with mitochondrial disease by facilitating cross-border cooperation and collaboration among national patient organisations.